COVALENT MODIFICATION OF POLYPEPTIDES WITH POLYETHYLENE GLYCOLS Russian patent published in 2000 - IPC

Abstract RU 2148586 C1

FIELD: biotechnology, medicine, peptides. SUBSTANCE: invention relates to compounds of the general formula R1-X-R2 where X means nonpeptide polymeric spacer and R1 and R2 are antagonist of interleukin-1 receptors or inhibitor of tumor necrosis factor. Compounds are synthesized by interaction of R1 and R2 containing or modified so that they have reactive cysteine with nonpeptide spacer which is able to form thioester bonds. Muteins are obtained by recombinant technology. EFFECT: decreased rate of elimination of therapeutic agent from body. 36 cl, 24 dwg, 4 tbl, 19 ex

Similar patents RU2148586C1

Title Year Author Number
PREPARING AND USING MONO- AND DI-PEGYLATED IL-10 2009
  • Blejzdell, Stiven, Dzh.
  • Katler, Kollett,M.
  • Paporello, Brittani, S.
  • Ambrozhelli, Aleksandr
RU2549702C2
METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS 2014
  • Oft Martin
RU2679889C2
FVIII MODIFICATION TREND SITE 2005
  • Pehn Klark Kv.
  • Merfi Dzhon I.
  • Mej Bejsong
  • Strauss Dzhonatan S.
  • Tzhandra Khendri
  • Chen Zhianmin
  • Barnett Tomas
  • Tang Liang
  • Vang Dekvian
RU2423380C2
METHOD FOR TREATING AND PREVENTING DISEASES CAUSED BY INCREASING CONTENTS OF A FACTOR INDUCING TUMOR CELL NECROSIS 1992
  • Dehvid F. Karmajkl
  • Kristofer G. Smit
  • Robert K. Tompson
  • Debora Rassell
  • Tadakhiko Kokhno
RU2166955C2
COMBINATION OF APO2L/TRAIL AND EGFR INHIBITOR FOR CANCER TREATMENT, METHOD IN VITRO OF APOPTOSIS INCREASE AND APPLICATION OF COMBINATION FOR OBTAINING MEDICATION FOR CANCER TREATMENT 2006
  • Ashkenazi Avi Dzh.
RU2429006C2
ANGIOPOIETIN-2-SPECIFIC COUPLING AGENTS 2005
  • Oliner Dzhonaton Dehniel
  • Grehkhem Kevin
RU2404992C2
COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER WITH ARGININE-DEPLETING AND IMMUNE-ONCOLOGICAL AGENTS 2017
  • Lowe, David
  • Rowlinson, Scott, W.
  • Alters, Susan
  • Agnello, Giulia
RU2771313C2
ISOLATED MOLECULE OF NUCLEIC ACID, WHICH CODES FUSED POLYPEPTIDE THAT IS ABLE TO BIND VESSEL ENDOTHELIOCYTES GROWTH FACTOR (VEGF), FUSED POLYPEPTIDE, COPIED EXPRESSIVE VECTOR, METHOD FOR PRODUCTION OF FUSED POLYPEPTIDE, TRAP OF VEGF, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT AND SET FOR TREATMENT OF VEGF-MEDIATED DISEASE OR CONDITION 2004
  • Dejli Tomas Dzh.
  • Fehndl Dzhejms P.
  • Papadopulos Nikolas Dzh.
RU2376373C2
HOMOGENOUS PREPARATIONS OF IL-28 AND IL-29 2004
  • Brehdi Lovell Dzh
  • Klacher Kevin M
  • Chan Chung
  • Dong Dennis L
  • Lju Khun J
  • Sheppard Pol O
  • Bukovski Tomas R
RU2518324C2
POLYPEPTIDE WITH ANTIVIRAL ACTIVITY, ITS PRODUCTION AND USE 2004
  • Brehdi Lovell Dzh.
  • Klacher Kevin M.
  • Chan Chung
  • Dong Dennis L.
  • Lju Khun J.
  • Sheppard Pol O.
  • Bukovski Tomas R.
RU2372356C2

RU 2 148 586 C1

Authors

Tompson Robert K.

Armz Lajmehn Dzh.

Ehvenz Ronald Dzh.

Brjuehr Majkl T.

Kono Tedekhajko

Dates

2000-05-10Published

1992-03-13Filed